Assesment of Satureja khuzestanica topical preparation chemotherapy-induced Mucositis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201412153106N20

Enrollment

Registered

2014-12-30

Start date

2014-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucositis. Other diseases of lip and oral mucosa

Interventions

Intervention 1: Intervention group: general oral care with Satureja Khuzestanica oral gel, from the first day up the end of cycle for 3 cycles. Intervention 2: Control group: standard drug therapy rec

Treatment - Drugs

Intervention group: general oral care with Satureja Khuzestanica oral gel, from the first day up the end of cycle for 3 cycles.

Control group: standard drug therapy recommended by the physician

Eligibility

Sex/Gender

All

Age

20 Years to 77 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: consciousness; being literate; chemotherapeutic management with drugs which induce mucositis; no stomatitis; no oral disease; no renal & liver disorders; no auto immune disease and diabetes; no fever and neutropenia; no recieved antibiotic & narcotic analgesic.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Mucositis. Timepoint: At the end of cycle for 3 cycles. Method of measurement: PROMS and OMAS questionnaires.	—

Secondary

Measure	Time frame
Mucositis. Timepoint: At the end of cycle for 3 cycles. Method of measurement: PROMS and OMAS questionnaires.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026